Skip to main content

Table 2 Characteristics of ESBL or AmpC-positive Salmonella isolates and transformed or transconjugated E. coli isolates analyzed in this study

From: Serotype epidemiology and multidrug resistance patterns of Salmonella enterica infecting humans in Italy

Serovar

Antimicrobial susceptibility testing

ASSuT

PCR

PBRT

AMX (mg/L)

CFPM (mg/L)

CAZ (mg/L)

CTX (mg/L)

FOX (diameter zone)

Additional resistances

  

S. rissen

>8

≤1

>4

≥2

7 mm

GEN, STR, STX, TET

Positive

blaCMY-2

IncA/C

monophasic S. typhimurium (1,4,[5],12:i:-)

>8

≥4

>4

≥2

26 mm

KAN, GEN, STR, STX, TET, TMP

Positive

blaCTX-M-15

IncFIA, IncFIIS

S. Paratyphi B

>8

≥4

>4

≥2

26 mm

nd

Negative

blaTEM-52

I1-Ig

E. coli transformed blaCTX-M-15

>8

≥4

>4

≥2

nd

nd

blaCTX-M-15

IncFIA

E. coli transformed blaTEM-52

>8

≥4

>4

≥2

nd

nd

blaTEM-52

I1-Ig

E. coli J53 blaCMY-2

>8

≤1

>4

≥2

nd

nd

blaCMY-2

IncA/C

E. coli J53 blaCTX-M-15

>8

≥4

>4

≥2

nd

nd

blaCTX-M-15

IncFIA

E. coli J53 blaTEM-52

>8

≥4

>4

≥2

nd

nd

blaTEM-52

I1-Ig

  1. AMX amoxicillin; CFPM cefepime; CAZ ceftazidime; CTX cefotaxime; FOX cefoxitin; KAN kanamycin; GEN gentamicin; STR streptomycin; SMX sulfamethoxazole; TET tetracycline; TMP trimethoprim; nd not detected